Showing results 2 to 3 of 3
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Sofosbuvir plus ribavirin for 12 16 or 24 weeks results in sustained virologic response over 97% in genotype 1 and 6 HCV infection in Hong Kong Proceeding/Conference:Hepatology International | 2015 | ||
Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong Journal:Alimentary Pharmacology & Therapeutics | 2016 |